Ads
-
Related conference
- COMPARATIVE EFFICIENCY OF SULFONYLUREA AND/OR DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN BASAL-SUPPORTED ORAL THERAPY IN JAPANESE PATIENTS WITH TYPE 2 DIABETES (JDDM39)
- Comparative evaluation of effects of combined oral anti-diabetic drugs (sulfonylurea plus pioglitazone and sulfonylurea plus metformin) over lipid parameters in type 2 diabetic patients
- DEVELOPMENT OF A TOPICAL GEL CONTAINING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR FOR WOUND HEALING APPLICATIONS
- Diabetes Mellitus Therapy Adherence and Therapy Characterization in Northeast Portugal: Classical Vs Dipeptidyl Peptidase IV (DPP-4) Inhibitors
- A prospective double blind clinical comparative study of extraction socket healing in patients with type 2 diabetes on oral hypoglycemic drugs
- In silico Molecular Docking Studies of Some Phytochemicals against Dipeptidyl peptidase 4
- Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach
- THE MAINTENANCE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN BLOOD SERUM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
- Association between Normative Oral Health Status and Self - Rated Oral Health among Type 2 Diabetes Mellitus Patients Attending a Teaching Dental Hospital
- The state of oral mucosa in patients with type 2 diabetes
